AI-Designed Enzymes Handle a Key Step in Making HIV Drug Lenacapavir
|
Making lenacapavir, a twice-yearly HIV prevention
drug, involves a chemical step where water is the enemy. An enzyme built to
join two molecules ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.